Search clinical trials for: Vytorin Niaspan

Total 126 results

Organon and Co
Merck Sharp & Dohme LLC

Completed

Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)

Hypercholesterolemia | Hyperlipidemia
University of Wisconsin, Madison

Completed

Organ Preservation Media Investigation

Kidney Transplant

United States
University of Miami

Completed

Vytorin in the Treatment of Alopecia Areata

Alopecia Areata

United States
Pfizer

Completed

Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO

Hemophilia A

Italy
EA Pharma Co., Ltd.

Terminated

Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid

Primary Biliary Cholangitis

Japan
Eisai Inc.

Withdrawn

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of 3 Subcutaneous and 1 Intravenous Dose of E6011 in Subjects With Active Crohn's Disease

Crohn's Disease
Merck Sharp & Dohme LLC

Completed

Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069)

Dyslipidemia
Klinikum Emden
Universitätsklinikum Hamburg-Eppendorf; Kantonsspital Baden; Kantonsspital Münsterlingen

Completed

Evaluating a CytoSorb Score in Septic Shock (ECSISS)

Severe Sepsis With Septic Shock

Germany
Hamdard University

Completed

Comparative Anti Helicobacter Pylori Efficacy Assessment of Unani Formulation and Quintuple Regimen

H.Pylori Infection
Atea Pharmaceuticals, Inc.

Recruiting

A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV

Hepatitis C | Hepatitis C, Chronic | HCV | Chronic Hepatitis C Virus | Hepatic Cirrhosis

Turkey, Brazil, Romania, Canada, Philippines, Pakistan, South Africa, Moldova, Republic of, India, Korea, Republic of, Mauritius
Brigham and Women's Hospital

Terminated

Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid

Inflammation | Cardiovascular Disease | Atherosclerosis | Dialysis

United States
University at Buffalo
Kaleida Health

Completed

To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects

Inflammation

United States
National Cheng-Kung University Hospital

Completed

Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis

Atherosclerosis

Taiwan
Institut de Médecine et d'Epidémiologie Appliquée...
Merck Sharp & Dohme LLC; Institut National de la Santé Et de la Recherche Médicale...

Completed

Short Duration Therapy of Acute Hepatitis C Genotypes 1 or 4 (SAHIV)

HIV | Acute Hepatitis C

France
Gachon University Gil Medical Center

Completed

Vascular and Metabolic Effects of Vytorin

Hypercholesterolemia

Korea, Republic of
University of Hawaii
United States Department of Defense

Completed

Study of Niacin on Endothelial Function in HIV-infected Subjects With Low High Density Lipoprotein Cholesterol Levels

HIV Infections | Dyslipidemia | Endothelial Dysfunction

United States
Organon and Co

Completed

Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED) (BRAVO)

Hypercholesterolemia
University of Virginia
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Comprehensive Magnetic Resonance of Peripheral Arterial Disease

Peripheral Artery Disease

United States
Abbott
QUASY

Completed

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Cardiovascular Diseases

Colombia, Mexico, Venezuela
Merck Sharp & Dohme LLC

Completed

A Study of Niaspan on Endothelium-Dependent and Endothelium-Independent Vascular Reactivity (0000-093)

Dyslipidemia
Cedars-Sinai Medical Center
Kos Pharmaceuticals; General Clinical Research Center (GCRC)

Completed

Benefit of Elevation of HDL-C on Cardiovascular Outcomes in Women

Coronary Artery Disease

United States
Organon and Co

Completed

Vytorin As Strategy To Reduce Dislipidemia In Adults (0653A-148)

Hyperlipidemia
Washington University School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Obesity and Nonalcoholic Fatty Liver Disease

Non-alcoholic Fatty Liver Disease

United States
Cedars-Sinai Medical Center
Roswell Park Cancer Institute

Completed

Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal

Prostate Cancer

United States
Tufts Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Niacin and Endothelial Function in Early CKD

Chronic Kidney Disease

United States
University of Oxford
Merck KGaA, Darmstadt, Germany

Unknown

Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function

Atherosclerosis

United Kingdom
Bronx VA Medical Center

Completed

Comparison of the Effect of Vytorin 10/80 Tablet Split Into 4 and Simvastatin 20 Milligrams on Low-density Lipoprotein (LDL) Cholesterol

Hypercholesterolemia

United States
Soroka University Medical Center

Unknown

The Two Most Common Ways Post-operative Eye Patch Are Therapeutic Contact Lenses (TCL) and Overnight Bandaging With Tight Bandage Patch: This Study is Designed to Determine the Most Effective Post-operative Care to Relief the Patient's Discomfort After Pterygium Excision Surgery

Pain, Postoperative | Pterygium of Both Eyes
Cedars-Sinai Medical Center

Completed

Benefit of Elevation of HDL-C in Women

Cardiovascular Outcomes

United States
North Texas Veterans Healthcare System
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis (ALPINE-SVG)

Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis | Intermediate Saphenous Vein Graft Lesions

United States
University of Miami

Terminated

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Diabetes Mellitus, Type 2 | Kidney Failure, Chronic | Hyperlipidemia

United States
University of Pennsylvania

Completed

Assessment Of Vascular Health After Niacin Therapy (AVANT) (AVANT)

Coronary Artery Disease | Peripheral Artery Disease | Carotid Artery Disease

United States
Nova Scotia Health Authority

Completed

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

Psychosis

Canada
GlaxoSmithKline

Completed

Study to Test GSK256073 in Patients With Dyslipidemia

Dyslipidemias | Dyslipidaemias

United States
Organon and Co

Completed

Ezetimibe Plus (+) Simvastatin Versus Atorvastatin Comparative Study (0653A-092)(COMPLETED)

Hypercholesterolemia
Organon and Co

Completed

A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED)

Hypercholesterolemia
Korea University

Withdrawn

Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)

Atherosclerosis

Korea, Republic of
University of Calgary
Heart and Stroke Foundation of Ontario

Completed

High-Density Lipoprotein (HDL) Modulation and Endothelial Function

Atherosclerosis

Canada
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis (ENTHRALL)

Dyslipidemias

United States
Baylor College of Medicine
Merck Sharp & Dohme LLC

Completed

Effects of Ezetimibe, Simvastatin, and Vytorin on Reducing L5 a Subfraction of LDL in Patients With Metabolic Syndrome. (Merck-123)

Metabolic Syndrome

United States
Organon and Co

Completed

Vytorin (10/20 Or 10/40) Compared to Atorvastatin (10 mg or 20 mg) in Patients With Coronary Artery Disease (0653A-126)(COMPLETED)

Hypercholesterolemia
Hospital Universitario 12 de Octubre
Merck Sharp & Dohme LLC

Completed

Vytorin on Carotid Intima-media Thickness and Overall Rigidity (VYCTOR)

Cardiovascular Diseases
October 6 University

Recruiting

Benefits of Trimetazidine in MAFLD Pateints (MAFLD)

Non-Alcoholic Fatty Liver Disease

Egypt
Gachon University Gil Medical Center

Completed

Vascular and Metabolic Effects of Vytorin vs Simvastatin

Hypercholesterolemia

Korea, Republic of
Federal University of Bahia
Escola Bahiana de Medicina e Saude Publica

Unknown

Pleiotropism of Statin Therapy in High Dose Versus Low Dose Combined With Ezetimibe

Endothelial Function

Brazil
Organon and Co

Completed

Ezetimibe (+) Simvastatin vs. Atorvastatin Comparative Study in DM or Metabolic Syndrome Patients (0653A-093)

Hypercholesterolemia
University of Maryland, Baltimore
Merck Sharp & Dohme LLC

Completed

Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment

Metabolic Syndrome

United States
Brasilia Heart Study Group

Completed

Additive Effect of Ezetimibe Upon Simvastatin During Myocardial Infarction

Myocardial Infarction

Brazil
Charite University, Berlin, Germany

Unknown

Evaluation of the Effect of NICOtinic Acid (Niacin) on Elevated Lipoprotein(a) Levels (NICOLa Study) (NICOLa)

Elevated Lipoprotein(a) Levels

Germany
University of Pennsylvania

Completed

The Genetics of Evoked Responses to Niacin and Endotoxemia: The GENE Study (GENE)

Healthy Volunteers

United States

Search clinical trials for: Vytorin Niaspan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations